ARCA BIOPHARMA INC (ABIO) Stock Earnings & Estimates
USA - NASDAQ:ABIO - US00211Y5069 - Common Stock
2.4 USD
-0.1 (-4%)
2.48 USD
+0.08 (+3.33%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||||||
| EBITDA YoY % growth | -9.68M | -11.44M -18.18% | -16.59M -45.02% | -18.68M -12.60% | -8.1M 56.64% | -5.79M 28.52% | -9.76M -68.57% | -19.319M -97.94% | -10.576M 45.26% | -7.281M 31.16% | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.69M | -11.46M -18.27% | -16.61M -44.94% | -18.71M -12.64% | -8.12M 56.60% | -5.81M 28.45% | -9.77M -68.16% | -19.335M -97.90% | -10.596M 45.20% | -7.296M 31.14% | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -10.08 71.85% | -4.53 55.06% | -2.50 44.81% | N/A | N/A | N/A | N/A | N/A -20.51% | N/A -30.50% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.10 37.50% | % | ||
| Q3 2022 Q2Q % growth | -0.16 51.52% | % | ||
| Q2 2022 Q2Q % growth | -0.22 35.29% | % | ||
| Q1 2022 Q2Q % growth | -0.23 30.30% | % | ||
| Q3 2021 Q2Q % growth | -0.33 | % | ||
| Q2 2021 Q2Q % growth | -0.34 53.42% | % | ||
| Q1 2021 Q2Q % growth | -0.33 60.24% | % | ||
| Q4 2020 Q2Q % growth | -0.61 20.78% | % | ||
| Q3 2020 Q2Q % growth | -0.33 56.58% | % | ||
| Q2 2020 Q2Q % growth | -0.73 35.96% | -2.63 | 1.90 | 72.26% |
| Q1 2020 Q2Q % growth | -0.83 55.38% | -2.08 | 1.25 | 60.11% |
| Q4 2019 Q2Q % growth | -0.77 | -1.01 | 0.24 | 23.75% |
| Q3 2019 Q2Q % growth | -0.76 | -1.33 | 0.57 | 42.68% |
| Q2 2019 Q2Q % growth | -1.14 | -1.90 | 0.76 | 39.91% |
| Q1 2019 Q2Q % growth | -1.86 | -2.02 | 0.16 | 7.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |